Russell Investments Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Sell
1,513
-303
-17% -$6.77K ﹤0.01% 3809
2026
Q1
$47.7K Sell
1,816
-322
-15% -$40.5K ﹤0.01% 3343
2025
Q4
$530K Sell
2,138
-6,425
-75% -$1.47M ﹤0.01% 2476
2025
Q3
$1.8M Buy
+8,563
New +$1.51M ﹤0.01% 1909
2024
Q2
– Sell
-211
Closed -$19.9K – 3597
2024
Q1
$19.9K Buy
211
+58
+38% +$5.11K ﹤0.01% 2771
2023
Q4
$11.1K Buy
153
+68
+80% +$4.02K ﹤0.01% 2815
2023
Q3
$5.3K Sell
85
-61
-42% -$5.62K ﹤0.01% 3134
2023
Q2
$14K Buy
146
+85
+139% +$8.47K ﹤0.01% 2907
2023
Q1
$6.1K Buy
61
+32
+110% +$4.9K ﹤0.01% 2934
2022
Q4
$5.1K Sell
29
-459
-94% -$302K ﹤0.01% 2865
2022
Q3
$466K Buy
488
+441
+938% +$438K ﹤0.01% 2274
2022
Q2
$31K Sell
47
-461
-91% -$286K ﹤0.01% 2762
2022
Q1
$351K Sell
508
-161
-24% -$124K ﹤0.01% 2328
2021
Q4
$604K Sell
669
-235
-26% -$223K ﹤0.01% 2374
2021
Q3
$908K Sell
904
-110
-11% -$81K ﹤0.01% 2231
2021
Q2
$658K Sell
1,014
-81
-7% -$56.2K ﹤0.01% 2488
2021
Q1
$809K Sell
1,095
-105
-9% -$84.7K ﹤0.01% 2332
2020
Q4
$928K Sell
1,200
-272
-18% -$214K ﹤0.01% 2149
2020
Q3
$1.46M Buy
1,472
+604
+70% +$641K ﹤0.01% 1875
2020
Q2
$900K Buy
868
+808
+1,347% +$813K ﹤0.01% 2119
2020
Q1
$48K Sell
60
-331
-85% -$346K ﹤0.01% 2871
2019
Q4
$487K Buy
+391
New +$630K ﹤0.01% 2404

Other funds holding GOSS

Russell Investments Group's GOSS Position: Q2 2026 in Review

Russell Investments Group reduced its Gossamer Bio (GOSS) stake by 17% in Q2 2026, selling an estimated $6.77K and leaving 1,513 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

Russell Investments Group first reported a position in GOSS in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.8M in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Russell Investments Group held 1,513 shares of Gossamer Bio worth $19.9K as of Q2 2026.
  • Russell Investments Group sold 303 Gossamer Bio shares in Q2 2026, an estimated $6.77K.
  • Gossamer Bio made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3809 holding.
  • Russell Investments Group first reported a position in Gossamer Bio in Q4 2019 and has held it in 22 quarters since.
  • Russell Investments Group's Gossamer Bio position peaked at $1.8M in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.